The Drug Eluting Balloon Market has experienced significant growth in recent years, driven by the increasing demand for minimally invasive treatments in the medical field. These innovative devices are used in the treatment of various cardiovascular diseases, such as coronary artery disease and peripheral artery disease. Drug eluting balloons offer several advantages over traditional treatments, including reduced risk of restenosis (reoccurrence of narrowed blood vessels), improved patient outcomes, and shorter recovery times.
The balloons are coated with anti-restenotic drugs that are released into the targeted vessel, preventing the regrowth of tissue and maintaining blood flow. The Drug Eluting Balloon Market is witnessing a surge in investments and research activities by key players to develop advanced drug eluting balloons with enhanced drug delivery capabilities. The rising prevalence of cardiovascular diseases and the increasing geriatric population are expected to further fuel market growth in the coming years.